Monday, 27 January 2014 00:00

Anticoagulation news items. Week commencing 27th January 2014


Antiplatelet Therapy for Stable Coronary Artery Disease in Atrial Fibrillation Patients on Oral Anticoagulant: A Nationwide Cohort Study

This study of 8,700 patients with AF and stable CAD (>12 months from an acute event) found combined vitamin K antagonist (VKA) plus antiplatelet was not associated with a reduced risk of MI/coronary death or thromboembolism vs. VKA monotherapy, but bleeding risk was increased.


Risk of drug-induced liver injury with the new oral anticoagulants: systematic review and meta-analysis

This analysis of 29 RCTs (n=152,116, mean follow-up 16 months) found that NOACs were not linked to increased risk of drug-induced liver injury (RR 0.90, 95% CI, 0.72 to 1.13, I2=0%). Similar results were obtained for individual NOACs.


The above records have been identified by UKMi and feature in the NICE Medicines Awareness Service.
Further details on this service can be found at: